Dave Humphrey

2022 - Ensysce Biosciences

In 2022, Dave Humphrey earned a total compensation of $780.6K as Chief Financial Officer at Ensysce Biosciences.

Compensation breakdown

Option Awards$438,562
Salary$328,333
Other$13,722
Total$780,617

Humphrey received $438.6K in option awards, accounting for 56% of the total pay in 2022.

Humphrey also received $328.3K in salary and $13.7K in other compensation.

Rankings

In 2022, Dave Humphrey's compensation ranked 3,551st out of 5,753 executives tracked by ExecPay. In other words, Humphrey earned more than 38.3% of executives.

ClassificationRankingPercentile
All
3,551
out of 5,753
38th
Division
Manufacturing
2,018
out of 3,133
36th
Major group
Chemicals And Allied Products
964
out of 1,419
32nd
Industry group
Drugs
902
out of 1,320
32nd
Industry
Pharmaceutical Preparations
657
out of 966
32nd
Source: SEC filing on October 17, 2024.

Humphrey's colleagues

We found three more compensation records of executives who worked with Dave Humphrey at Ensysce Biosciences in 2022.

2022

David Humphrey

Ensysce Biosciences

Chief Financial Officer

2022

Lynn Kirkpatrick

Ensysce Biosciences

Chief Executive Officer

2022

Geoff Birkett

Ensysce Biosciences

Chief Commercial Officer

News

In-depth

You may also like